We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $3.64B
1-Year Est. Return 83.38%
This Fund
S&P 500
This Quarter Est. Return
+49.74%
1 Year Est. Return
+83.38%
3 Year Est. Return
+239.61%
5 Year Est. Return
+330.19%
10 Year Est. Return
+1,383.86%
AUM
$3.64B
AUM Growth
+$913M
Cap. Flow
+$245M
Cap. Flow %
6.73%
Top 10 Hldgs %
40.93%
Holding
1,250
New
158
Increased
429
Reduced
585
Closed
75

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$72.2M
2
AVGO icon
Broadcom
AVGO
+$27.9M
3
SNDK
Sandisk
SNDK
+$15M
4
AAPL icon
Apple
AAPL
+$13.9M
5
MU icon
Micron Technology
MU
+$12.9M

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$5.34M
2
APLS
Apellis Pharmaceuticals
APLS
+$3.27M
3
AEM icon
Agnico Eagle Mines
AEM
+$2.54M
4
NEM icon
Newmont
NEM
+$2.3M
5
FOLD
Amicus Therapeutics
FOLD
+$2.06M

Sector Composition

Rank Sector Weight
1 Technology 56.05%
2 Healthcare 8.58%
3 Communication Services 8.31%
4 Consumer Discretionary 7.81%
5 Industrials 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSTR icon
201
Strategy Inc
MSTR
$56.7B
$1.98M 0.05%
22,796
+2,635
+13% +$382K
T icon
202
AT&T
T
$176B
$1.98M 0.05%
95,538
+35,003
+58% +$869K
PTGX icon
203
Protagonist Therapeutics
PTGX
$9.43B
$1.98M 0.05%
16,118
-6,749
-30% -$705K
MTSI icon
204
MACOM Technology Solutions
MTSI
$20.5B
$1.95M 0.05%
5,122
+677
+15% +$225K
ERAS icon
205
Erasca
ERAS
$5.66B
$1.92M 0.05%
104,575
-8,641
-8% -$124K
SRE icon
206
Sempra
SRE
$55B
$1.9M 0.05%
20,467
-1,802
-8% -$168K
VKTX icon
207
Viking Therapeutics
VKTX
$4.07B
$1.89M 0.05%
48,407
-6,572
-12% -$212K
D icon
208
Dominion Energy
D
$57.9B
$1.88M 0.05%
27,536
-1,599
-5% -$104K
TRV icon
209
Travelers Companies
TRV
$77B
$1.88M 0.05%
5,687
-194
-3% -$58.8K
PCVX icon
210
Vaxcyte
PCVX
$9.1B
$1.88M 0.05%
32,277
-4,119
-11% -$224K
PTCT icon
211
PTC Therapeutics
PTCT
$5.78B
$1.87M 0.05%
22,973
-10,353
-31% -$748K
RYTM icon
212
Rhythm Pharmaceuticals
RYTM
$7.07B
$1.87M 0.05%
16,805
-5,982
-26% -$541K
OXY icon
213
Occidental Petroleum
OXY
$60B
$1.86M 0.05%
38,363
+4,345
+13% +$247K
UTHR icon
214
United Therapeutics
UTHR
$20.9B
$1.86M 0.05%
3,432
-1,255
-27% -$707K
BIIB icon
215
Biogen
BIIB
$32.6B
$1.85M 0.05%
8,560
-3,401
-28% -$651K
CGON icon
216
CG Oncology
CGON
$6.62B
$1.85M 0.05%
25,972
-4,716
-15% -$308K
HAL icon
217
Halliburton
HAL
$30.9B
$1.81M 0.05%
53,305
-5,957
-10% -$233K
ARWR icon
218
Arrowhead Research
ARWR
$12.2B
$1.81M 0.05%
22,190
-17,568
-44% -$1.3M
DNTH icon
219
Dianthus Therapeutics
DNTH
$6.05B
$1.81M 0.05%
18,547
+4,297
+30% +$375K
SRRK icon
220
Scholar Rock
SRRK
$6.74B
$1.8M 0.05%
32,759
-14,334
-30% -$692K
NBIX icon
221
Neurocrine Biosciences
NBIX
$15.8B
$1.79M 0.05%
10,634
-7,053
-40% -$1.05M
COGT icon
222
Cogent Biosciences
COGT
$6.03B
$1.79M 0.05%
46,226
-10,825
-19% -$379K
MIRM icon
223
Mirum Pharmaceuticals
MIRM
$6.15B
$1.79M 0.05%
15,263
-6,920
-31% -$695K
NUE icon
224
Nucor
NUE
$59.2B
$1.78M 0.05%
7,992
+1,954
+32% +$442K
SLS icon
225
SELLAS Life Sciences
SLS
$2.8B
$1.78M 0.05%
120,607
+8,813
+8% +$60.8K
7 8
9
10 11

Similar funds

VGM
Voyager Global Management New York $3.63B AUM 5.73% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.65B AUM 41.77% 1-Year Est. Return
CC
Carrhae Capital London, United Kingdom $3.62B AUM 34.35% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $3.66B AUM 32.08% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Profund Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Profund Advisors held 1,250 positions worth $3.64B, up 34% from $2.72B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors deployed $245M of net new capital in Q2 2026, opening 158 new positions and adding to 429 existing holdings. Its largest new stake was Honeywell Aerospace: 24,902 shares worth $5.51M.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 43% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Honeywell, an estimated $5.34M trimmed.

  • Profund Advisors's largest Q2 2026 buy was Honeywell Aerospace: 24,902 shares worth $5.51M.
  • Profund Advisors added most to NVIDIA in Q2 2026, an estimated $72.2M increase.
  • Profund Advisors's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.34M.
  • Profund Advisors fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $3.27M.
  • Profund Advisors's ten largest holdings make up 41% of its $3.64B portfolio in Q2 2026.
  • Profund Advisors opened 158 new positions and closed 75 in Q2 2026.
  • Profund Advisors's portfolio value rose 34% quarter-over-quarter to $3.64B.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.